Literature DB >> 1567395

AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor.

K Weindel1, D Marmé, H A Weich.   

Abstract

PCR cloning and cDNA sequencing have been used to identify mRNAs of two splice products of the vascular endothelial growth factor (VEGF) gene, VEGF121 and VEGF165, in cells isolated from Kaposi's sarcomas (KS) of AIDS patients (AIDS-KS). As demonstrated by Northern blot analysis, AIDS-KS cells as well as tumor cells show a high expression level of the VEGF gene as compared to primary human vascular cells like smooth muscle cells or endothelial cells. In addition to the lower expression of the gene, vascular cells express a 3.9 kb band together with a 3.2 kb band instead of a 3.9 kb and a 4.3 kb band in AIDS-KS cells. Our data suggest that the angiogenic properties of AIDS-KS cells might be mediated by the secretion of this growth factor and that this factor alone or in combination with other endothelial mitogens may be involved in endothelial proliferation associated with Kaposi's sarcoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567395     DOI: 10.1016/s0006-291x(05)80313-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

1.  Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Interleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.

Authors:  Brian R Lane; Jianguo Liu; Paul J Bock; Dominique Schols; Michael J Coffey; Robert M Strieter; Peter J Polverini; David M Markovitz
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 3.  Molecular biology of KSHV in relation to AIDS-associated oncogenesis.

Authors:  Whitney Greene; Kurt Kuhne; Fengchun Ye; Jiguo Chen; Fuchun Zhou; Xiufen Lei; Shou-Jiang Gao
Journal:  Cancer Treat Res       Date:  2007

4.  Essential requirement of CCAAT/enhancer binding proteins in embryogenesis.

Authors:  Valérie Bégay; Jeske Smink; Achim Leutz
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

Review 5.  Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.

Authors:  Qiliang Cai; Suhbash C Verma; Jie Lu; Erle S Robertson
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

6.  The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.

Authors:  G Barillari; L Albonici; O Franzese; A Modesti; F Liberati; P Barillari; B Ensoli; V Manzari; G Santeusanio
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

7.  Hyaluronic acid hydrogels with controlled degradation properties for oriented bone regeneration.

Authors:  Jennifer Patterson; Ruth Siew; Susan W Herring; Angela S P Lin; Robert Guldberg; Patrick S Stayton
Journal:  Biomaterials       Date:  2010-06-23       Impact factor: 12.479

8.  Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.

Authors:  F Samaniego; P D Markham; R Gendelman; Y Watanabe; V Kao; K Kowalski; J A Sonnabend; A Pintus; R C Gallo; B Ensoli
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma.

Authors:  L F Brown; K Tognazzi; H F Dvorak; T J Harrist
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

10.  Vascular endothelial growth factor in thyroid cyst fluids.

Authors:  Andrea Hofmann; Alois Gessl; Friedrich Girschele; Clemens Novotny; Oskar Kienast; Anton Staudenherz; Robert Dudczak; Shuren Li
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.